#ASCO21: Watch out Bristol Myers, J&J is back at ASCO with some competitive BCMA CAR-T data
Bristol Myers Squibb and bluebird beat Johnson & Johnson to market back in March with their BCMA CAR-T drug, Abecma, for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
